News | Information Technology | November 08, 2017

Fujifilm Highlights Women's Health and Pediatrics at RSNA 2017

In addition to product offerings, company will host an evening symposium on breast cancer care

Fujifilm Highlights Women's Health and Pediatrics at RSNA 2017

November 8, 2017 — Fujifilm Healthcare will showcase a variety of imaging and information technology solutions at the 2017 Radiological Society of North America (RSNA) annual meeting, including its Women’s Health portfolio and a brand-new Pediatrics portfolio. At RSNA 2017, the company will feature the two dedicated areas in its booth to demonstrate how the comprehensive portfolio of solutions can help healthcare providers impact patient care.

Fujifilm's portfolio of Women's Health solutions was built smarter based on insights that impact patient care, according to the company. The integrated, multimodality suite of solutions designed to help improve breast cancer patient care, in addition to an ultrasound-guided breast biopsy system, includes:

  • The Aspire Cristalle 3-D Mammography System, now with digital breast tomosynthesis (DBT). The system is designed to optimize image acquisition, regardless of breast composition, at a low dose with state-of-the-art, Hexagonal Close Pattern (HCP) image capture technology and intelligent image processing, optimizing contrast and dose based on auto recognition of breast characteristics. It helps deliver patient comfort with its patented Comfort Paddle and provides a scalable platform for future technologies;
  • For even further enhanced imaging excellence, Fujifilm is offering its Dynamic Visualization II for Mammography (DVIIm) image processing software with the Aspire Cristalle (FFDM). The second generation offers intelligent auto-recognition of breast tissue, implant and structural characteristics to intelligently adapt image contrast and density, for enhanced diagnostic visibility. DVIIm provides improved contrast and density stability throughout the entire exposure region and achieves improved visibility across a wide range of breast compositions including the presence of implants; and
  • Synapse 5 PACS (picture archiving and communication system), one of the fastest medical imaging solutions in the industry, according to Fujifilm. The system offers subsecond delivery of extremely large datasets. Its underlying architecture promotes significantly less bandwidth consumption and tighter security.

In addition to exhibiting its latest technology in women's health, Fujifilm offer RSNA attendees a complimentary symposium, Innovations in Mammography for Improved Patient Care. The event will convene U.S. healthcare experts for an evening of networking and discussion along with a distinguished panel of global opinion leaders in women's health to explore the latest strategies and technologies in the use of digital breast tomosynthesis in the fight against breast cancer.

Fujifilm also announced the launch of its brand-new Pediatrics portfolio. Featuring a comprehensive range of digital radiography, healthcare information technology (IT) and ultrasound solutions, the Pediatrics portfolio is designed to help tackle one of healthcare's most complex and unique challenges: imaging children. Products in the portfolio focus on sharper images with gentler dose and patient comfort, as well as everything needed to present and protect data.

The company will also highlight several of its SonoSite portable point-of-care ultrasound units. The SonoSite SII empowers efficiency through an intuitive, smart user interface that adapts to imaging needs. The system is portable and can be used across multiple hospital environments, including a zero-footprint option for space-constrained rooms. The SonoSite Edge II Ultrasound System offers an enhanced imaging experience through transducer innovations like DirectClear and Armored Cable Technology. It is designed to be truly portable and used in the most rigorous environments.

For RSNA attendees, Fujifilm will host an evening symposium on Nov. 27 at the Chicago Museum of History for an evening of networking and education. Attendees will be able to learn from industry experts and participate in the discussion as a distinguished panel of global opinion leaders explores the latest strategies and technologies in the use of digital breast tomosynthesis in the fight against breast cancer.

For more information: www.fujimed.com

Related Content

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire)

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire).

News | Artificial Intelligence | May 29, 2020
May 29, 2020 — GE Healthcare announced U.S.
The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control.

The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control. Getty Images

Feature | Coronavirus (COVID-19) | May 28, 2020 | By Matthew A. Michela
One year after being proposed, federal rules to advance interoperability in healthcare and create easier access for p
The opportunity to converge the silos of data into a cross-functional analysis can provide immense value during the COVID-19 outbreak and in the future

Getty Images

Feature | Coronavirus (COVID-19) | May 28, 2020 | By Jeff Vachon
In the midst of the coronavirus pandemic normal
AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.
Headlines around the world the past several months declared that...
In April, the U.S. Food and Drug Administration (FDA) cleared Intelerad’s InteleConnect EV solution for diagnostic image review on a range of mobile devices.
Feature | PACS | May 27, 2020 | By Melinda Taschetta-Millane
Fast, easily accessible patient images are crucial in this day and age, as imaging and medical records take on a new
The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

News | Coronavirus (COVID-19) | May 26, 2020
May 26, 2020  — Philips Healthcare recently received 510(k) clearance from the U.S.
An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019.

An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019. Photo by Dave Fornell.

News | Ultrasound Imaging | May 26, 2020
May 12, 2020 — DiA Imaging Analysis, a provider of AI based ultrasound analysis solutions, said it received a governm
a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of pol

a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of polyethylene microspheres (diameter, 20 μm) dispersed in agar. The inset shows a zoomed-in view of the region boxed with a yellow dashed line. In addition, the yellow boxes are signal profiles along the xy and z axes across the microsphere centre, as well as the corresponding full width at half-maximum values. c Normalized absorption spectra of Hb, HbO2 and gold nanoparticles (AuNPs). The spectrum for the AuNPs was obtained using a USB4000 spectrometer (Ocean Optics, Dunedin, FL, USA), while the spectra for Hb and HbO2 were taken from http://omlc.org/spectra/haemoglobin/index.html. The vertical dashed lines indicate the five wavelengths used to stimulate the three absorbers: 710, 750, 780, 810 and 850 nm. Optoacoustic signals were filtered into a low-frequency band (red) and high-frequency band (green), which were used to reconstruct separate images.

News | Breast Imaging | May 26, 2020
May 26, 2020 — Breast cancer is the most common cancer in women.
 Recently the versatility of mixed and augmented reality products has come to the forefront of the news, with an Imperial led project at the Imperial College Healthcare NHS Trust. Doctors have been wearing the Microsoft Hololens headsets whilst working on the front lines of the COVID pandemic, to aid them in their care for their patients. IDTechEx have previously researched this market area in its report “Augmented, Mixed and Virtual Reality 2020-2030: Forecasts, Markets and Technologies”, which predicts th

Doctors wearing the Hololens Device. Source: Imperial.ac.uk

News | Artificial Intelligence | May 22, 2020
May 22, 2020 — Recently the versatility of